NIH ARPA-H-SOL-24-101: 2024 ARPA-H Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT)

No Applicants // Limit: 2 // Tickets Available: 2 

The PRINT program aims to transform organ biofabrication by leveraging recent advances in 3D bioprinting, cell manufacturing, biomaterials, modeling, and tissue engineering. The PRINT program will assemble the necessary tools to facilitate production from a human cell source to a patient matched biofabricated organ to restore at least 40% normal organ function as demonstrated in a large animal model. 

Areas of Interest:

• Technical Area 1 (TA1): Generation of all necessary organ cell types (Phase I)
• Technical Area 2 (TA2): Large scale manufacturing of organ cell types (Phase I & II)
• Technical Area 3 (TA3): Organ Biofabrication and in vivo testing (Phase I and II)